Skip to main content
NVST
NYSE Life Sciences

Envista Lifts 2026 Guidance as Q3 Buyback and Cash Flow Details Emerge

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$27.19
Mkt Cap
$4.367B
52W Low
$18.77
52W High
$30.42
52W Position info
45% above low
Off High info
11% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

NVST sits 45% above its 52-week low of $18.77 on elevated volume (2.1× avg).

Summary

Envista raised its full-year 2026 earnings guidance alongside third-quarter results, though the release did not disclose the revised figures. Q3 sales were USD 691.5 million versus an IBES estimate of USD 688.7 million. Q3 headline numbers were distorted by a $428M operating profit and $2.62 diluted EPS from foreign currency translation gains — non-cash items that did not affect adjusted results. Cash generation softened: operating cash flow was $78M versus $79M a year ago and free cash flow $63M versus $68M. The company repurchased 386K shares for about $10M, leaving roughly $273M of capacity on its buyback program. The guidance raise is the real change to the story; the translation gain should be stripped out when judging underlying performance.

At the time of this announcement, NVST was trading at $27.19 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $18.77 to $30.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

NVST - Latest Insights

NVST
Nov 10, 2026, 5:26 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $25.84
Real-time Price: $23.59 info
Change: -$2.25 (-9%) info
Market Cap: $3.785B info
NVST
Nov 04, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $23.59 info
Change: -$3.61 (-13%) info
Market Cap: $3.785B info
NVST
Nov 04, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $23.59 info
Change: -$3.61 (-13%) info
Market Cap: $3.785B info
NVST
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $27.26
Real-time Price: $23.59 info
Change: -$3.68 (-13%) info
Market Cap: $3.785B info
NVST
Aug 05, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $23.59 info
Change: -$3.31 (-12%) info
Market Cap: $3.785B info